U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828757) titled 'Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer' on Feb. 11.
Brief Summary: This prospective interventional clinical study evaluates the efficacy of nanocrystalline megestrol combined with standard care in improving appetite and weight compared to standard care alone in first-line treatment of NSCLC.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Non Small Cell Lung Cancer
Intervention:
DRUG: nanocrystalline megestrol oral suspension + PD-1/L1 inhibitor combined with chemotherapy
Oral suspension of nanocrystalline megestrol is taken orally once ...